These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 25354444)

  • 1. Universal screening test based on analysis of circulating organ-enriched microRNAs: a novel approach to diagnostic screening.
    Sheinerman KS; Umansky S
    Expert Rev Mol Diagn; 2015 Mar; 15(3):329-38. PubMed ID: 25354444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of organ-enriched microRNAs in plasma as an approach to development of Universal Screening Test: feasibility study.
    Sheinerman KS; Tsivinsky VG; Umansky SR
    J Transl Med; 2013 Dec; 11():304. PubMed ID: 24330742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating brain-enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseases.
    Sheinerman KS; Toledo JB; Tsivinsky VG; Irwin D; Grossman M; Weintraub D; Hurtig HI; Chen-Plotkin A; Wolk DA; McCluskey LF; Elman LB; Trojanowski JQ; Umansky SR
    Alzheimers Res Ther; 2017 Nov; 9(1):89. PubMed ID: 29121998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential of microRNAs as biofluid markers of neurodegenerative diseases--a systematic review.
    Danborg PB; Simonsen AH; Waldemar G; Heegaard NH
    Biomarkers; 2014 Jun; 19(4):259-68. PubMed ID: 24678935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood-Based Biomarker Screening with Agnostic Biological Definitions for an Accurate Diagnosis Within the Dimensional Spectrum of Neurodegenerative Diseases.
    Baldacci F; Lista S; O'Bryant SE; Ceravolo R; Toschi N; Hampel H;
    Methods Mol Biol; 2018; 1750():139-155. PubMed ID: 29512070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs as biomarkers for clinical studies.
    Pogribny IP
    Exp Biol Med (Maywood); 2018 Feb; 243(3):283-290. PubMed ID: 28914096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysregulated microRNAs in neurodegenerative disorders.
    Lau P; de Strooper B
    Semin Cell Dev Biol; 2010 Sep; 21(7):768-73. PubMed ID: 20080199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miRNA as markers for the diagnostic screening of colon cancer.
    Ahmed FE
    Expert Rev Anticancer Ther; 2014 Apr; 14(4):463-85. PubMed ID: 24580550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs in the kidney: novel biomarkers of acute kidney injury.
    Aguado-Fraile E; Ramos E; Conde E; Rodríguez M; Liaño F; García-Bermejo ML
    Nefrologia; 2013 Nov; 33(6):826-34. PubMed ID: 24158125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating microRNAs: a novel class of biomarkers to diagnose and monitor human cancers.
    Zen K; Zhang CY
    Med Res Rev; 2012 Mar; 32(2):326-48. PubMed ID: 22383180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Sex Perspective in Neurodegenerative Diseases: microRNAs as Possible Peripheral Biomarkers.
    Piscopo P; Bellenghi M; Manzini V; Crestini A; Pontecorvi G; Corbo M; Ortona E; Carè A; Confaloni A
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small RNAs have a large impact: circulating microRNAs as biomarkers for human diseases.
    Weiland M; Gao XH; Zhou L; Mi QS
    RNA Biol; 2012 Jun; 9(6):850-9. PubMed ID: 22699556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating microRNAs: potential biomarkers for common malignancies.
    Khoury S; Tran N
    Biomark Med; 2015; 9(2):131-51. PubMed ID: 25689901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating microRNAs: Association with disease and potential use as biomarkers.
    Reid G; Kirschner MB; van Zandwijk N
    Crit Rev Oncol Hematol; 2011 Nov; 80(2):193-208. PubMed ID: 21145252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating microRNAs in Neurodegenerative Diseases.
    Grasso M; Piscopo P; Crestini A; Confaloni A; Denti MA
    Exp Suppl; 2015; 106():151-169. PubMed ID: 26608203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating microRNAs: macro-utility as markers of prostate cancer?
    Selth LA; Tilley WD; Butler LM
    Endocr Relat Cancer; 2012 Aug; 19(4):R99-R113. PubMed ID: 22492480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The path to biomarker-based diagnostic criteria for the spectrum of neurodegenerative diseases.
    Baldacci F; Mazzucchi S; Della Vecchia A; Giampietri L; Giannini N; Koronyo-Hamaoui M; Ceravolo R; Siciliano G; Bonuccelli U; Elahi FM; Vergallo A; Lista S; Giorgi FS; Hampel H
    Expert Rev Mol Diagn; 2020 Apr; 20(4):421-441. PubMed ID: 32066283
    [No Abstract]   [Full Text] [Related]  

  • 18. Conventional and novel diagnostic biomarkers of acute myocardial infarction: a promising role for circulating microRNAs.
    Recchioni R; Marcheselli F; Olivieri F; Ricci S; Procopio AD; Antonicelli R
    Biomarkers; 2013 Nov; 18(7):547-58. PubMed ID: 24025051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of serum-circulating miRNA profiling for the identification of breast cancer biomarkers.
    Mar-Aguilar F; Rodríguez-Padilla C; Reséndez-Pérez D
    Methods Mol Biol; 2014; 1165():71-80. PubMed ID: 24839019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating microRNAs as novel minimally invasive biomarkers for breast cancer.
    Heneghan HM; Miller N; Lowery AJ; Sweeney KJ; Newell J; Kerin MJ
    Ann Surg; 2010 Mar; 251(3):499-505. PubMed ID: 20134314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.